David R Holtgrave1, Jennifer Kates. 1. Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA. dholtgrave@jhsph.edu
Abstract
BACKGROUND: The central evaluative question about a national HIV prevention program is whether that program affects HIV incidence. Numerous factors may influence incidence, including public investment in HIV prevention. Few studies, however, have examined the relationship between public investment and the HIV epidemic in the United States. METHODS: This 2006 exploratory analysis examined the period from 1978 through 2006 using a quantitative, lagged, correlational analysis to capture the relationship between national HIV incidence and Centers for Disease Control and Prevention's HIV prevention budget in the United States over time. RESULTS: The analyses suggest that early HIV incidence rose in advance of the nation's HIV prevention investment until the mid-1980s (1-year lag correlation, r=0.972, df=2, p <0.05). From that point on, it appears that the nation's investment in HIV prevention became a strong correlate of HIV incidence (1-year lag correlation, r=-0.905, df=18, p <0.05). CONCLUSIONS: This exploratory study provides correlational evidence of a relationship between U.S. HIV incidence and the federal HIV prevention budget over time, and calls for further analysis of the role of funding and other factors that may influence the direction of a nation's HIV epidemic.
BACKGROUND: The central evaluative question about a national HIV prevention program is whether that program affects HIV incidence. Numerous factors may influence incidence, including public investment in HIV prevention. Few studies, however, have examined the relationship between public investment and the HIV epidemic in the United States. METHODS: This 2006 exploratory analysis examined the period from 1978 through 2006 using a quantitative, lagged, correlational analysis to capture the relationship between national HIV incidence and Centers for Disease Control and Prevention's HIV prevention budget in the United States over time. RESULTS: The analyses suggest that early HIV incidence rose in advance of the nation's HIV prevention investment until the mid-1980s (1-year lag correlation, r=0.972, df=2, p <0.05). From that point on, it appears that the nation's investment in HIV prevention became a strong correlate of HIV incidence (1-year lag correlation, r=-0.905, df=18, p <0.05). CONCLUSIONS: This exploratory study provides correlational evidence of a relationship between U.S. HIV incidence and the federal HIV prevention budget over time, and calls for further analysis of the role of funding and other factors that may influence the direction of a nation's HIV epidemic.
Authors: Stephanie K Behel; Duncan A MacKellar; Linda A Valleroy; Gina M Secura; Trista Bingham; David D Celentano; Beryl A Koblin; Marlene Lalota; Douglas Shehan; Lucia V Torian Journal: J Urban Health Date: 2008-07-12 Impact factor: 3.671
Authors: Benedict I Truman; Ramal Moonesinghe; Yolanda T Brown; Man-Huei Chang; Jonathan H Mermin; Hazel D Dean Journal: Public Health Rep Date: 2020 Jul/Aug Impact factor: 2.792
Authors: Stephanie K Y Choi; David R Holtgrave; Jean Bacon; Rick Kennedy; Joanne Lush; Frank McGee; George A Tomlinson; Sean B Rourke Journal: AIDS Behav Date: 2016-06